Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04741594 · ClinicalTrials.gov registry record · NA

Osseodensification and Implant Survival and Success

A NA study of Missing Teeth, sponsored by University of Oklahoma.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT04741594: Completed NA study of Missing Teeth, sponsored by University of Oklahoma.

NCT04741594 is a NA study of Missing Teeth that has completed, run by University of Oklahoma. The registered enrollment target is 22 participants, below the 29-participant average among 4 other Missing Teeth trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04741594, a NA study of Missing Teeth, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

Approximately 40 implants from patients seeking treatment at the University of Oklahoma, College of Dentistry will be recruited for this study. Osteotomies will be prepared using the osseodensification technique and implants will be placed immediately after. The implants will be from a single manufacturer (Roxolid® SLA® Bone Level Tapered; Straumann®, Institut Straumann AG, Basel, Switzerland). Volumetric analysis of alveolar ridge will be studied using intra-surgical direct measurements and CBCT imaging. A custom stent will be fabricated to standardize the clinical and radiographic measurements at 2mm, 3mm, and 4mm apical to the alveolar crest. Changes in peri-implant bone density will be analyzed on standardized periapical and bitewing radiographs, using the ImageJ software (National Institute of Health, Bethesda, Maryland, USA). Implant stability quotient (ISQ) values will be recorded with a resonance frequency analysis system (Osstell®, Gothenburg, Sweden). Calibrated examiners will assess implant survival and biological or restorative complications and failures. Sites will be evaluated throughout osseointegration and one year after final restoration is delivered.

Primary Outcome

Bone width at 2, 3, 4 mm apical to edentulous alveolar ridge. Not all measurements were able to be performed on each site due to anatomic limitations per site. Results were reported at 2 mm below the alveolar crest and 4 mm below the alveolar crest, when applicable. Measurements were performed by caliper measurements during the procedure and by CBCT followup approximately 3 months after implant placement

Conditions Studied

Interventions

  • DEVICE Densah

Study Locations (1)

Oklahoma

  • College of Dentistry, OUHSC - Oklahoma City

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2021-07-01
Est. Completion 2023-09-13
Phase NA
University of Oklahoma

358 total trials

What the finished NCT04741594 record still lists

NCT04741594 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 29-participant average among 4 other Missing Teeth trials with a reported enrollment target (24% lower).

The record links to 1 condition, with Missing Teeth appearing as the primary indexed condition, and to 1 intervention - of which Densah is the first listed.

NCT04741594 reports a single indexed study location in Oklahoma.

Frequently Asked Questions

What is clinical trial NCT04741594 about?

NCT04741594 is a clinical study titled "Osseodensification and Implant Survival and Success". Approximately 40 implants from patients seeking treatment at the University of Oklahoma, College of Dentistry will be recruited for this study. Osteotomies will be prepared using the osseodensification technique and implants will be placed immediately after. The implants will be from a single manufa...

What is the current status of trial NCT04741594?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2021-07-01. Estimated completion is 2023-09-13.

What conditions does trial NCT04741594 study?

This clinical trial studies the following conditions: Missing Teeth.

What interventions are being tested in trial NCT04741594?

The interventions under investigation include: Densah (DEVICE).

Who is sponsoring clinical trial NCT04741594?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04741594 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Missing Teeth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04741594, the US trial registry maintained by the National Library of Medicine. NCT04741594 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.